SCHEMBL13061005

SCHEMBL13061005

CCc1cccc(-c2cccc(C(=O)N(C)C)c2)c1OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 2/20 0.49
CYP3A4 P08684 1/20 0.47
MAP4K1 Q92918 1/20 0.47
ERN1 O75460 3/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
CECR2 Q9BXF3 5/20 0.45
BRD9 Q9H8M2 2/20 0.43
HSD17B2 P37059 1/20 0.43
PDK2 Q15119 1/20 0.43
BRD4 O60885 4/20 0.42
TRIM24 O15164 1/20 0.42
TAF1 P21675 1/20 0.42
SMARCA2 P51531 1/20 0.42
SMARCA4 P51532 1/20 0.42
BRPF1 P55201 1/20 0.42
EP300 Q09472 1/20 0.42
PBRM1 Q86U86 1/20 0.42
CREBBP Q92793 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13005444 0.88 KCNA5 (0.51) KCNA5CYP3A4MAP4K1ERN1LMNA
SCHEMBL13060646 0.80 FYN (0.52)
SCHEMBL13060800 0.77 TAS1R3 (0.41)
SCHEMBL13061114 0.77 TAS1R3 (0.41)
SCHEMBL13060892 0.75 CTSL (0.41)
SCHEMBL13060890 0.75 CTSL (0.41)
SCHEMBL13061023 0.75 ROCK2 (0.51)
SCHEMBL13006175 0.74 CYP1A2 (0.47) CYP3A4LMNAHPGDTSHRHSD17B2
SCHEMBL13060640 0.74 TAS1R3 (0.40)
SCHEMBL17066912 0.74 CYP3A4 (0.53) KCNA5CYP3A4MAP4K1ERN1CECR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed